ES2181413T3 - Nuevas dihidropiridinas sustituidas en 2 con heterociclo. - Google Patents
Nuevas dihidropiridinas sustituidas en 2 con heterociclo.Info
- Publication number
- ES2181413T3 ES2181413T3 ES99915743T ES99915743T ES2181413T3 ES 2181413 T3 ES2181413 T3 ES 2181413T3 ES 99915743 T ES99915743 T ES 99915743T ES 99915743 T ES99915743 T ES 99915743T ES 2181413 T3 ES2181413 T3 ES 2181413T3
- Authority
- ES
- Spain
- Prior art keywords
- substituted
- alkyl
- phenyl
- hydroxy
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 8
- 125000004432 carbon atom Chemical group C* 0.000 abstract 8
- 229910052739 hydrogen Inorganic materials 0.000 abstract 8
- 239000001257 hydrogen Substances 0.000 abstract 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 7
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 abstract 6
- 229910052736 halogen Inorganic materials 0.000 abstract 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 5
- -1 trifluoromethoxy, carboxyl Chemical group 0.000 abstract 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 4
- 125000004122 cyclic group Chemical group 0.000 abstract 4
- 125000005843 halogen group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000006823 (C1-C6) acyl group Chemical group 0.000 abstract 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229930195734 saturated hydrocarbon Natural products 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Dihidropirimidinas con la fórmula general (I) o su forma isomérica (Ia) en las que R1 representa fenilo, furilo, tienilo, piridilo, cicloalquilo con 3 a 6 átomos de carbono o un resto de fórmula donde los sistemas de anillos antes expuestos están sustituidos eventualmente una o varias veces, de forma igual o diferente, con sustituyentes seleccionados del grupo formado por halógeno, triflúormetilo, nitro, ciano, triflúormetoxi, carboxilo, hidroxilo, alcoxi C1-C6, alcoxicarbonilo C1-C6 y alquilo C1-C6 que a su vez puede estar sustituido con arilo con 6 a 10 átomos de carbono o halógeno, y/o los sistemas de anillos expuestos están sustituidos eventualmente con grupos de fórmula -S- R6, NR7R8, CO-NR9R10, SO2-CF3 y -A-CH2-R11, en las que R6 significa fenilo que está sustituido eventualmente con halógeno, R7, R8, R9 y R10 son iguales o diferentes y significan hidrógeno, fenilo, fenilo sustituido con hidroxi, hidroxi, acilo C1-C6 o alquilo C1-C6 que a su vez puede estar sustituido con hidroxi, alcoxicarbonilo C1-C6, fenilo o fenilo sustituido con hidroxi, A significa un resto O, S, SO o SO2, R11 significa fenilo que está sustituido eventualmente de una a varias veces, de forma igual o diferente, con sustituyentes seleccionados del grupo formado por halógeno, nitro, triflúormetilo, alquilo C1-C6 y alcoxi C1-C6, R2 representa un resto de fórmula -OR12 o -NR13R14, en las que R12 significa hidrógeno, alcoxicarbonilo C1-C6 o un resto de hidrocarburo C1-C8 saturado o insaturado, de cadena lineal, ramificado o cíclico, que contiene eventualmente uno o dos miembros de cadena de heteroátomos iguales o diferentes del grupo formado por O, CO, NH, -N-alquilo-(C1-C4), -N-(alquilo(C1- C4))2, S o SO2 y que eventualmente está sustituido con halógeno, nitro, ciano, hidroxi, arilo con 6 a 10 átomos de carbono o aralquilo con 6 a 10 átomos de carbono, heteroarilo o un grupo de fórmula - NR15R16, en la que R15 y R16 son iguales o diferentes y significan hidrógeno, bencilo o alquilo C1-C6, R13 y R14 son iguales o diferentes y significan hidrógeno, alquilo C1-C6 o cicloalquilo con 3 a 6 átomos de carbono, R3 representa hidrógeno, amino o un resto de fórmula representa formilo, ciano o triflúormetilo, o representa un resto de hidrocarburo saturado o insaturado, de cadena lineal, ramificado o cíclico, con hasta 8 átomos de carbono que eventualmente está sustituido una o varias veces, de forma igual o diferente, con ariloxi con 6 a 10 átomos de carbono, azido, ciano, hidroxi, carboxilo, alcoxicarbonilo C1- C6, un anillo heterocíclico con 5 a 7 miembros, alquiltío C1-C6, alcoxi C1-C6 que a su vez puede estar sustituido con azido o amino, y/o que está sustituido con triazolilo que a su vez puede estar sustituido hasta 3 veces con alcoxicarbonilo C1-C6, y/o que puedeestar sustituido con grupos de fórmula -OSO2-CH3 o (CO)a-NR17R18, en las que a significa un número de 0 a 1, R17 y R18 son iguales o diferentes y significan hidrógeno o arilo, aralquilo con 6 a 10 átomos de carbono, o significan alquilo C1-C6 que eventualmente está sustituido con alcoxicarbonilo C1-C6, hidroxilo, fenilo o bencilo, donde el fenilo o el bencilo están sustituidos eventualmente una o varias veces, de forma igual o diferente, con hidroxi, carboxilo, alquilo C1-C6 o alcoxi C1-C6, o alquilo C1-C6 que eventualmente está sustituido con grupos de fórmula NH-CO-CH3 o NH-CO-CF3, R4 representa hidrógeno, alquilo C1-C4, acetilo o benzoílo, D representa un átomo de oxígeno o de azufre, R5 representa hidrógeno, halógeno o alquilo de cadena lineal o ramificado con hasta 6 átomos de carbono, y sus sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19817262A DE19817262A1 (de) | 1998-04-18 | 1998-04-18 | Neue 2-heterocyclisch substituierte Dihydropyrimidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2181413T3 true ES2181413T3 (es) | 2003-02-16 |
Family
ID=7864971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99915743T Expired - Lifetime ES2181413T3 (es) | 1998-04-18 | 1999-04-07 | Nuevas dihidropiridinas sustituidas en 2 con heterociclo. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6503913B1 (es) |
| EP (1) | EP1073653B1 (es) |
| JP (1) | JP2002512244A (es) |
| KR (1) | KR20010042787A (es) |
| CN (1) | CN1134434C (es) |
| AR (1) | AR015765A1 (es) |
| AU (1) | AU3420599A (es) |
| CA (1) | CA2328876A1 (es) |
| DE (2) | DE19817262A1 (es) |
| ES (1) | ES2181413T3 (es) |
| GT (1) | GT199900055A (es) |
| ID (1) | ID26308A (es) |
| PE (1) | PE20000428A1 (es) |
| SV (1) | SV1999000049A (es) |
| WO (1) | WO1999054329A1 (es) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000058302A1 (de) * | 1999-03-25 | 2000-10-05 | Bayer Aktiengesellschaft | Dihydropyrimidine und ihre verwendung zur behandlung von hepatitis b |
| WO2000078730A1 (en) | 1999-06-23 | 2000-12-28 | Ajinomoto Co., Inc. | Novel dihydropyrimidine derivatives |
| WO2001045712A1 (de) * | 1999-12-22 | 2001-06-28 | Bayer Aktiengesellschaft | Arzneimittelkombinationen gegen virale erkrankungen |
| DE10012549A1 (de) * | 2000-03-15 | 2001-09-20 | Bayer Ag | Arzneimittel gegen virale Erkrankungen |
| DE10012824A1 (de) * | 2000-03-16 | 2001-09-20 | Bayer Ag | Arzneimittel gegen virale Erkrankungen |
| DE10012823A1 (de) | 2000-03-16 | 2001-09-20 | Bayer Ag | Arzneimittel gegen virale Erkrankungen |
| DE10013125A1 (de) * | 2000-03-17 | 2001-09-20 | Bayer Ag | Arzneimittel gegen virale Erkrankungen |
| US8193247B2 (en) * | 2006-03-24 | 2012-06-05 | The Feinstein Institute For Medical Research | Phenolic hydrazone macrophage migration inhibitory factor inhibitors |
| CN101104617B (zh) * | 2006-07-10 | 2010-06-23 | 北京摩力克科技有限公司 | 二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途 |
| CN101104604B (zh) | 2006-07-10 | 2011-03-02 | 北京摩力克科技有限公司 | 光学纯二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途 |
| CN100567277C (zh) * | 2007-02-02 | 2009-12-09 | 广东东阳光药业有限公司 | 一种含n五元芳香杂环甲脒及其盐的制备方法 |
| CN100453542C (zh) * | 2007-04-30 | 2009-01-21 | 广东东阳光药业有限公司 | 2-杂环取代的二氢嘧啶消旋化合物的拆分方法 |
| WO2008154820A1 (fr) * | 2007-06-18 | 2008-12-24 | Zhang, Zhongneng | Thiazolyl-dihydropyrimidines à substitution carbéthoxy |
| CN101328170B (zh) * | 2007-06-18 | 2011-09-14 | 张中能 | 一种氟苯基-取代噻唑二氢嘧啶 |
| PT2514750E (pt) * | 2007-06-18 | 2014-01-23 | Sunshine Lake Pharma Co Ltd | Tiazolil dihidropirimidinas substituídas com bromo-fenilo |
| WO2010069147A1 (zh) * | 2008-12-17 | 2010-06-24 | 张中能 | 二氢嘧啶类化合物、其组合物及其应用 |
| AR089671A1 (es) | 2012-01-06 | 2014-09-10 | Janssen R & D Ireland | 1,4-dihidropirimidinas 4,4-disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b |
| AU2013216935C1 (en) | 2012-02-08 | 2017-12-14 | John Emmerson Campbell | Heteroaryl compounds and methods of use thereof |
| US20130267517A1 (en) | 2012-03-31 | 2013-10-10 | Hoffmann-La Roche Inc. | Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
| MX2014011749A (es) * | 2012-03-31 | 2015-01-22 | Hoffmann La Roche | 4-metil-dihidropirimidinas novedosas para el tratamiento y la prolifaxis de la infeccion por el virus de la hepatitis b. |
| MY182403A (en) * | 2012-08-24 | 2021-01-25 | Sunshine Lake Pharma Co Ltd | Dihydropyrimidine compounds and their application in pharmaceuticals |
| CN103664925B (zh) * | 2012-09-07 | 2018-01-23 | 广东东阳光药业有限公司 | 杂芳基取代的二氢嘧啶类化合物及其在药物中的应用 |
| CA2881322A1 (en) | 2012-09-10 | 2014-03-13 | F. Hoffmann-La Roche Ag | 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
| CA2920415A1 (en) | 2013-11-19 | 2015-05-28 | Sunshine Lake Pharma Co., Ltd. | Dihydropyrimidine compounds and their application in pharmaceuticals |
| KR102284944B1 (ko) | 2013-11-27 | 2021-08-03 | 선샤인 레이크 파르마 컴퍼니 리미티드 | 다이하이드로피리미딘 유도체 및 이의 중간산물의 제조 방법 |
| MX2016012573A (es) | 2014-03-28 | 2018-02-19 | Sunshine Lake Pharma Co Ltd | Compuestos de dihidropirimidina y su aplicacion en productos farmaceuticos. |
| AU2016214799A1 (en) | 2015-02-07 | 2017-06-15 | Sunshine Lake Pharma Co., Ltd. | Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals |
| WO2016161268A1 (en) | 2015-04-01 | 2016-10-06 | Enanta Pharmaceuticals, Inc. | Hepatitis b antviral agents |
| US10738035B2 (en) | 2015-05-13 | 2020-08-11 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| WO2017011552A1 (en) * | 2015-07-13 | 2017-01-19 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
| US10301255B2 (en) | 2015-07-22 | 2019-05-28 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| BR112018005861B1 (pt) | 2015-09-23 | 2022-11-22 | Reata Pharmaceuticals, Inc | Compostos derivados de ácido oleanólico modificado com c4 para a inibição de il-17, composição farmacêutica e usos terapêuticos dos ditos compostos |
| CA3004147C (en) * | 2015-11-04 | 2019-09-10 | Qilu Pharmaceutical Co., Ltd. | Crystal form, preparation method and intermediate of dihydropyrido ring compound |
| WO2017136403A1 (en) | 2016-02-02 | 2017-08-10 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
| KR102398439B1 (ko) | 2016-03-07 | 2022-05-16 | 이난타 파마슈티칼스, 인코포레이티드 | B형 간염 항바이러스제 |
| EP3468561A4 (en) | 2016-06-10 | 2019-12-04 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
| SG10202100724UA (en) | 2016-07-29 | 2021-03-30 | Sunovion Pharmaceuticals Inc | Compounds and compositions and uses thereof |
| BR112019001407A2 (pt) | 2016-07-29 | 2019-07-09 | Sunovion Pharmaceuticals Inc. | compostos e composições e usos dos mesmos |
| MX2020000523A (es) | 2017-08-02 | 2020-08-20 | Sunovion Pharmaceuticals Inc | Compuestos de isocromano y usos de los mismos. |
| CN107501257B (zh) * | 2017-08-17 | 2020-05-29 | 山东大学 | 二氢嘧啶-三氮唑类衍生物及其制备方法与应用 |
| SG11202001685TA (en) | 2017-08-28 | 2020-03-30 | Enanta Pharm Inc | Hepatitis b antiviral agents |
| SG11202003320SA (en) * | 2017-10-18 | 2020-05-28 | Sunshine Lake Pharma Co Ltd | Dihydropyrimidine compounds and uses thereof in medicine |
| WO2019113173A1 (en) | 2017-12-06 | 2019-06-13 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
| US10723733B2 (en) | 2017-12-06 | 2020-07-28 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| US11058678B2 (en) | 2018-01-22 | 2021-07-13 | Enanta Pharmaceuticals, Inc. | Substituted heterocycles as antiviral agents |
| US10729688B2 (en) | 2018-03-29 | 2020-08-04 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| US12060340B2 (en) | 2018-06-20 | 2024-08-13 | Reata Pharmaceuticals, Inc | Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith |
| TW202024093A (zh) | 2018-09-21 | 2020-07-01 | 美商安塔製藥公司 | 作為抗病毒劑之官能化雜環 |
| EP3883570A4 (en) | 2018-11-21 | 2022-07-13 | Enanta Pharmaceuticals, Inc. | FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS |
| JP7703449B2 (ja) | 2019-03-14 | 2025-07-07 | スミトモ・ファーマ・アメリカ・インコーポレイテッド | イソクロマニル化合物の塩およびその結晶体、ならびにそれらの製造方法、治療用途および医薬組成物 |
| WO2020247444A1 (en) | 2019-06-03 | 2020-12-10 | Enanta Pharmaceuticals, Inc, | Hepatitis b antiviral agents |
| US11472808B2 (en) | 2019-06-04 | 2022-10-18 | Enanta Pharmaceuticals, Inc. | Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents |
| WO2020247561A1 (en) | 2019-06-04 | 2020-12-10 | Enanta Pharmaceuticals, Inc, | Hepatitis b antiviral agents |
| WO2021007488A1 (en) | 2019-07-11 | 2021-01-14 | Enanta Pharmaceuticals, Inc. | Substituted heterocycles as antiviral agents |
| CN120248001A (zh) | 2019-07-19 | 2025-07-04 | 里亚塔医药公司 | C17极性的-取代的杂芳族合成三萜类化合物及其使用方法 |
| WO2021055425A2 (en) | 2019-09-17 | 2021-03-25 | Enanta Pharmaceuticals, Inc. | Functionalized heterocycles as antiviral agents |
| CN112707910A (zh) * | 2019-10-24 | 2021-04-27 | 广东东阳光药业有限公司 | 二氢嘧啶类化合物及其在药物中的应用 |
| US11802125B2 (en) | 2020-03-16 | 2023-10-31 | Enanta Pharmaceuticals, Inc. | Functionalized heterocyclic compounds as antiviral agents |
| CN113512035B (zh) * | 2021-04-26 | 2023-11-24 | 山东大学 | 二氢嘧啶-泊马度胺缀合物及其制备方法与应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH550189A (de) | 1971-01-08 | 1974-06-14 | Ciba Geigy Ag | Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren. |
| CH569043A5 (es) | 1973-01-23 | 1975-11-14 | Ciba Geigy Ag | |
| DE3234684A1 (de) | 1982-09-18 | 1984-03-22 | Bayer Ag, 5090 Leverkusen | Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
-
1998
- 1998-04-18 DE DE19817262A patent/DE19817262A1/de not_active Withdrawn
-
1999
- 1999-04-07 AU AU34205/99A patent/AU3420599A/en not_active Abandoned
- 1999-04-07 US US09/673,597 patent/US6503913B1/en not_active Expired - Fee Related
- 1999-04-07 EP EP99915743A patent/EP1073653B1/de not_active Expired - Lifetime
- 1999-04-07 KR KR1020007011526A patent/KR20010042787A/ko not_active Ceased
- 1999-04-07 ES ES99915743T patent/ES2181413T3/es not_active Expired - Lifetime
- 1999-04-07 ID IDW20002114A patent/ID26308A/id unknown
- 1999-04-07 DE DE59902470T patent/DE59902470D1/de not_active Expired - Fee Related
- 1999-04-07 CA CA002328876A patent/CA2328876A1/en not_active Abandoned
- 1999-04-07 CN CNB998051705A patent/CN1134434C/zh not_active Expired - Fee Related
- 1999-04-07 WO PCT/EP1999/002345 patent/WO1999054329A1/de not_active Ceased
- 1999-04-07 JP JP2000544668A patent/JP2002512244A/ja active Pending
- 1999-04-15 PE PE1999000310A patent/PE20000428A1/es not_active Application Discontinuation
- 1999-04-15 AR ARP990101748A patent/AR015765A1/es unknown
- 1999-04-16 SV SV1999000049A patent/SV1999000049A/es unknown
- 1999-04-16 GT GT199900055A patent/GT199900055A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1073653A1 (de) | 2001-02-07 |
| AU3420599A (en) | 1999-11-08 |
| US6503913B1 (en) | 2003-01-07 |
| DE59902470D1 (de) | 2002-10-02 |
| GT199900055A (es) | 2000-10-07 |
| CN1134434C (zh) | 2004-01-14 |
| JP2002512244A (ja) | 2002-04-23 |
| DE19817262A1 (de) | 1999-10-21 |
| HK1037188A1 (en) | 2002-02-01 |
| EP1073653B1 (de) | 2002-08-28 |
| KR20010042787A (ko) | 2001-05-25 |
| SV1999000049A (es) | 2000-07-04 |
| PE20000428A1 (es) | 2000-06-25 |
| CN1297449A (zh) | 2001-05-30 |
| AR015765A1 (es) | 2001-05-16 |
| ID26308A (id) | 2000-12-14 |
| WO1999054329A1 (de) | 1999-10-28 |
| CA2328876A1 (en) | 1999-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2186354T3 (es) | Uso de dihidropirimidinas como medicamentos y nuevas sustancias para el tratamiento de hepatitis b. | |
| AR015765A1 (es) | Dihidropirimidinas 2 heterociclicamente sustituidas, proceso para su preparacion, medicamentos que los contienen, proceso para la preparacion de los mismosuso de dichos dihidropirimidinas para la preparacion de un medicamento. | |
| AR018187A1 (es) | Derivados de 1,4-dihidro-1,3-diazinas y 3,4-dihidro-1,3-diazinas, procedimiento para su preparacion, medicamentos, procedimiento para la produccion de los mismos y el uso de los mismos para la produccion de medicamentos | |
| AR055592A1 (es) | Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace) | |
| ES387562A1 (es) | Procedimiento de 1,4-dihidropiridinas con efecto dilatador de los vasos coronarios. | |
| ES2189234T3 (es) | Nuevos derivados de taxano. | |
| AR066606A1 (es) | Compuestos de heteroarilamida pirimidona | |
| ES2191484T3 (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa. | |
| YU49359B (sh) | N-(3-benzofuranil)urea derivati | |
| CO4900061A1 (es) | Piridinas y bifenilos substituidos | |
| CO5140110A1 (es) | Nuevos antibioticos macrolidos | |
| CO5680430A2 (es) | Derivados de 1-benzol-piperazina como inhibidores de la captacion de glicina para el ratamiento de psicosis | |
| ES2081563T3 (es) | Benzamidas. | |
| CO4870759A1 (es) | Piridinas condensadas biciclicas | |
| ES2175919T3 (es) | Derivados del camptothecin con actividad antitumoral. | |
| CO5690585A2 (es) | Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor | |
| NI200900037A (es) | Derivados de 2-aril-6-fenil-imidazo[1,2-alfa] piridinas, su preparación y su aplicación en terapéutica. | |
| ES2188225T3 (es) | Dihydro-(1,2,3)triazolo-(4,5-d)dippirimidin-7-ona- | |
| ES403583A1 (es) | Procedimiento para la produccion de derivados de fenil-imi-dazoli-alcanilo. | |
| AR064517A1 (es) | Pirimidinionas biciclicas y sus usos | |
| CO4900066A1 (es) | Derivados de tetrahidroquinolina | |
| AR042067A1 (es) | Derivados de anilinopirazol utiles en el tratamiento de la diabetes | |
| AR066605A1 (es) | Derivados de heteroarilamida pirimidona | |
| ES420211A1 (es) | Un procedimiento para preparar 4-hidroxi-6-arilpirimidinas. | |
| ES2040215T3 (es) | Procedimiento para preparar nuevos tiazoles y oxazoles sustituidos. |